Intertek Group Selects PerkinElmer as a Preferred Global Vendor for Instrumentation Technologies

PerkinElmer, Inc. (NYSE: PKI), a global company focused on improving the health and safety of people and the environment, today announced that Intertek Group plc, a leading international provider of quality and safety services to a wide range of industries, has selected PerkinElmer as its preferred vendor for the majority of its instrumentation requirements. Under the agreement, PerkinElmer’s instrumentation will be considered at over 1000 Intertek sites worldwide.

"As an organization focused on providing professionalism and high quality service to our clients globally, we are confident that PerkinElmer instruments will consistently perform at the level that our laboratories require,” said Brent Mackin, vice president for Laboratory Services, Intertek Oil, Chemical and Agri Division. "PerkinElmer has also consistently delivered an equally high level of service and technical support for our evolving needs, and we look forward to furthering this successful relationship.”

The preferred vendor agreement, which covers all PerkinElmer analytical instrumentation and related reagents, will streamline the Intertek purchasing process for PerkinElmer products worldwide and is expected to be valued at several million dollars.

Intertek provides laboratory testing, consulting, cargo inspection and certification services for industries from specialty chemicals and petroleum products to consumer products and pharmaceuticals. Its laboratories employ multiple technologies, including Inductively Coupled Plasma (ICP), Atomic Absorption Spectroscopy (AAS) and UV/Visible Spectroscopy – applications, which require robust, high-performance instrumentation; such as PerkinElmer’s Optima™ ICP-OES, AAnalyst^TM atomic absorption systems and LAMBDA^TM UV/Vis families.

One key benefit of the agreement is the potential for standardization of laboratory equipment and procedures throughout Intertek’s laboratory locations, thereby minimizing transition times as laboratory staff moves across sites, domestically or internationally. The agreement also allows Intertek’s laboratory managers to focus on core business functions rather than expending resources on multiple purchase negotiations.

"Intertek’s performance record has established it as a market leader in laboratory outsourcing in the oil and chemical sectors, which provides PerkinElmer an opportunity to grow as a strategic partner as well,” said Richard Begley, Ph.D., president, PerkinElmer Analytical Sciences, PerkinElmer.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and their environment. The Company reported revenue of $1.8 billion in 2007, has approximately 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

About Intertek

Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace.

Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 23,000 people in 110 countries around the world. For more information, visit www.intertek.com.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) markets into which we sell our products decline or do not grow as anticipated; (4) our failure to adequately protect our intellectual property; (5) the loss of any of our licenses or licensed rights; (6) our ability to compete effectively; (7) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (8) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (9) disruptions in the supply of raw materials and supplies; (10) our ability to produce an adequate quantity of products to meet our customers' demands; (11) the manufacture and sale of products may expose us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with health care industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) restrictions in our credit agreements; (18) our ability to realize the full value of our intangible assets; and (19) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.